Sathguru’s healthcare practice lead Pushpa Vijayaraghavan deliberated the way forward for Indian biosimilars industry as part of the CII Lifesciences Conclave. The panel included leadership from Biocon, Intas, Gennova, Lupin and IIT Mumbai. The panel discussed current momentum, regulatory considerations, evolving commercial landscape globally and implications for Indian industry to advance to the next sphere of global presence in this segment.
